<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="research-article" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Pharmacol.</journal-id>
<journal-title>Frontiers in Pharmacology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Pharmacol.</abbrev-journal-title>
<issn pub-type="epub">1663-9812</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">849102</article-id>
<article-id pub-id-type="doi">10.3389/fphar.2022.849102</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Pharmacology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>&#x3b1;2-macroglobulin-rich serum as a master inhibitor of inflammatory factors attenuates cartilage degeneration in a mini pig model of osteoarthritis induced by &#x201c;idealized&#x201d; anterior cruciate ligament reconstruction</article-title>
<alt-title alt-title-type="left-running-head">Zhao et al.</alt-title>
<alt-title alt-title-type="right-running-head">
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fphar.2022.849102">10.3389/fphar.2022.849102</ext-link>
</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Zhao</surname>
<given-names>Ruipeng</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wei</surname>
<given-names>Xiaochun</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhang</surname>
<given-names>Chengming</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wu</surname>
<given-names>Hongru</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Xiang</surname>
<given-names>Chuan</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Li</surname>
<given-names>Haoqian</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Duan</surname>
<given-names>Wangping</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Duan</surname>
<given-names>Zhiqing</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Li</surname>
<given-names>Chunjiang</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhao</surname>
<given-names>Yu</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Huang</surname>
<given-names>Lingan</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1613808/overview"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Department of Orthopaedics</institution>, <institution>The Second Hospital of Shanxi Medical University. Shanxi Key Laboratory of Bone and Soft Tissue Injury Repair</institution>, <addr-line>Taiyuan</addr-line>, <country>China</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Shanxi Institute of Sports Science</institution>, <addr-line>Taiyuan</addr-line>, <country>China</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Department of Biochemistry and Molecular Biology</institution>, <institution>School of Basic Medical Sciences</institution>, <institution>Shanxi Medical University</institution>, <addr-line>Taiyuan</addr-line>, <country>China</country>
</aff>
<aff id="aff4">
<sup>4</sup>
<institution>Department of Pain Medicine</institution>, <institution>Sanya Central Hospital of Hainan Medical College</institution>, <addr-line>Sanya</addr-line>, <country>China</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1031871/overview">Tharmarajan Ramprasath</ext-link>, Georgia State University, United States</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1475234/overview">Venkata Naga Lakshmi Ramarao Sure</ext-link>, Tulane University, United States</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1175767/overview">Stalinraja Maruthamuthu</ext-link>, University of California, San Francisco, United States</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1256165/overview">Nandakumar Natarajan</ext-link>, The University of Texas Health Science Center at Tyler, United States</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Lingan Huang, <email>huang_3469@163.com</email>
</corresp>
<fn fn-type="other">
<p>This article was submitted to Inflammation Pharmacology, a section of the journal Frontiers in Pharmacology</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>05</day>
<month>09</month>
<year>2022</year>
</pub-date>
<pub-date pub-type="collection">
<year>2022</year>
</pub-date>
<volume>13</volume>
<elocation-id>849102</elocation-id>
<history>
<date date-type="received">
<day>05</day>
<month>01</month>
<year>2022</year>
</date>
<date date-type="accepted">
<day>05</day>
<month>08</month>
<year>2022</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2022 Zhao, Wei, Zhang, Wu, Xiang, Li, Duan, Duan, Li, Zhao and Huang.</copyright-statement>
<copyright-year>2022</copyright-year>
<copyright-holder>Zhao, Wei, Zhang, Wu, Xiang, Li, Duan, Duan, Li, Zhao and Huang</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>Post-traumatic osteoarthritis is a special type of osteoarthritis and a common disease, with few effective treatments available. &#x3b1;2-Macroglobulin (&#x3b1;2M) is important to chondral protection in post-traumatic osteoarthritis. However, its injection into xenogeneic joint cavities involves safety hazards, limiting clinical applications. Exploring serum &#x3b1;2M-enriching strategies and the therapeutic effect and mechanism of &#x3b1;2M-rich serum (&#x3b1;2MRS) autologous joint injection to treat post-traumatic osteoarthritis has significant value. In the present study, a unique filtration process was used to obtain &#x3b1;2MRS from human and mini pig serum. We evaluated the potential of &#x3b1;2MRS in protecting against post-surgery cartilage degeneration. We identify the potential of &#x3b1;2MRS in reducing the expression of inflammatory cytokines and factors that hasten cartilage degeneration in post-operative conditions leading to post-traumatic osteoarthritis. The potential of &#x3b1;2MRS was analyzed in interleukin-1&#x3b2; induced human chondrocytes and mini pig models. In the chondrocyte model, &#x3b1;2MRS significantly promoted human chondrocyte proliferation and reduced apoptosis and chondrocyte catabolic cytokine gene transcription and secretion. The anterior cruciate ligament autograft reconstruction model of mini pigs was randomized into groups, operated on, and injected with &#x3b1;2MRS or saline. The results showed that &#x3b1;2MRS injection significantly suppressed the levels of inflammatory factors, improved gait, and showed significantly lower cartilage degeneration than the groups that did not receive &#x3b1;2MRS injections. This study highlights the chondroprotective effects of &#x3b1;2MRS, elucidated its potential applications against cartilage degeneration, and could provide a basis for the clinical translation of &#x3b1;2MRS.</p>
</abstract>
<kwd-group>
<kwd>osteoarthritis</kwd>
<kwd>&#x3b1;2M-rich serum</kwd>
<kwd>anterior cruciate ligament</kwd>
<kwd>articular cartilage</kwd>
<kwd>inflammation</kwd>
<kwd>mini pig</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="s1">
<title>Introduction</title>
<p>Anterior cruciate ligament (ACL) rupture, one of the most common joint injuries in young people, is conventionally treated using surgical ACL reconstruction (ACL-R). However, even with the best surgical techniques available, these patients remain at a high risk for post-traumatic osteoarthritis (PTOA) (<xref ref-type="bibr" rid="B1">Barenius et al., 2014</xref>; <xref ref-type="bibr" rid="B2">Bj&#xf6;rnsson et al., 2016</xref>; <xref ref-type="bibr" rid="B33">Wang et al., 2020</xref>). Recently, researchers developed an &#x201c;idealized&#x201d; ACL autograft reconstruction (IACL-R) model (<xref ref-type="bibr" rid="B3">Bryan et al., 2011</xref>; <xref ref-type="bibr" rid="B9">Han et al., 2018</xref>). Notably, the authors found that cartilage degeneration still occurred despite this reconstruction and concluded that there was a significant correlation between the expression of inflammatory factors and cartilage injury. Moreover, other studies have indicated that catabolic proteases and cytokines reach their peak levels within 48&#xa0;h after joint injury, initiating cell death and cartilage matrix degeneration (<xref ref-type="bibr" rid="B18">Lieberthal et al., 2015</xref>; <xref ref-type="bibr" rid="B10">Heard et al., 2016</xref>; <xref ref-type="bibr" rid="B20">Maerz et al., 2018</xref>). Thus, early intervention to reduce the expression of these catabolic proteases and cytokines is critical to prevent or delay cartilage degeneration.</p>
<p>&#x3b1;2-macroglobulin (&#x3b1;2M), a tetrameric macromolecular glycoprotein, is mainly synthesized and secreted into the body fluids by liver epithelial parenchymal cells (<xref ref-type="bibr" rid="B28">Rehman et al., 2013</xref>). To date, &#x3b1;2M has been shown to play an important role in the diagnosis of diseases, prediction of liver fibrosis staging (<xref ref-type="bibr" rid="B11">Ho et al., 2010</xref>), non-invasive diagnosis of type II diabetes (<xref ref-type="bibr" rid="B5">Chung et al., 2016</xref>), and the treatment of various diseases, including alleviating pain in subacromial bursitis, lateral epicondylitis, Achilles tendonitis, spinal intervertebral discogenic (<xref ref-type="bibr" rid="B22">Montesano and Cuellar, 2015</xref>; <xref ref-type="bibr" rid="B6">Cuellar et al., 2016</xref>), and jaw osteoradionecrosis (<xref ref-type="bibr" rid="B17">Li S. et al., 2019</xref>). Moreover, some studies have demonstrated that supplemental intra-articular &#x3b1;2M provides chondral protection in PTOA (<xref ref-type="bibr" rid="B34">Wang et al., 2014</xref>; <xref ref-type="bibr" rid="B37">Zhang et al., 2017</xref>; <xref ref-type="bibr" rid="B15">Li et al., 2019</xref>). However, &#x3b1;2M is expensive. More importantly, the long-term injection of &#x3b1;2M, a blood protein component, into the xenogeneic joint cavity involves safety hazards, such as immune rejection, which limits its clinical application. This study used ultrafiltration centrifugation to explore suitable centrifugation conditions, in an attempt to enrich &#x3b1;2M in serum, and finally prepare &#x3b1;2M-rich serum (&#x3b1;2MRS). The ultimate purpose of the &#x3b1;2MRS preparation is for clinical application and disease prevention and treatment. Therefore, its biological safety, efficacy, and specific mechanism of action need to be accurately evaluated and verified. We hypothesized that &#x3b1;2MRS could significantly reduce the expression of inflammatory factors in synovial fluid, promote early recovery of the gait, and effectively attenuate cartilage degeneration. This study will greatly promote the translation of &#x3b1;2MRS for clinical applications.</p>
</sec>
<sec sec-type="materials|methods" id="s2">
<title>Materials and methods</title>
<sec id="s2-1">
<title>Patient samples and experimental animals</title>
<p>All procedures in this study, including <italic>in vitro</italic> and <italic>in vivo</italic> experiments, were approved by the Ethics Committee of the Second Hospital of Shanxi Medical University (NO. SYDL2019001). Human chondrocytes used in this study were derived from the articular cartilage library of Shanxi Key Laboratory of Bone and Soft Tissue Injury Repair. All patients provided informed consent, and all procedures were approved by the Ethics Committee of the Second Hospital of Shanxi Medical University (NO. 2019YX260). Based on the purpose of this study, under the guidance of statistical experts, the number of samples numbersin this study was six. For the <italic>in vitro</italic> experiments, a sample size of six was used. For the <italic>in vivo</italic> experiments, the number of animals in each group was determined as six. Patient baseline characteristics were as follows: age, 64 &#xb1; 3.38 (years); sex, female (<italic>n</italic> &#x3d; 4)/male (<italic>n</italic> &#x3d; 2); height, 163 &#xb1; 3.53 (cm); weight: 65 &#xb1; 3.85 (kg). Mini pigs were purchased from the Beijing Shichuang Century Mini pig Breeding Base (Certificate number: SCXX (jing)2013-0008). All animals were housed at the China Institute for Radiation Protection (Certificate number: SYXK (Jin)2016-0002).</p>
</sec>
<sec id="s2-2">
<title>Reagents</title>
<p>The following antibodies were used in this study: collagen-2 (Col-2, ab34712, Abcam), matrix metalloproteinase -3 (MMP-3, bs-0413R, Bioss), MMP-9 (bs-4593R, Bioss), MMP-13 (K009743P, Solarbio), Col-10 (bs-0554R, Bioss), and Runt-related transcription factor 2 (Runx-2, ab76956, Abcam).</p>
</sec>
<sec id="s2-3">
<title>&#x3b1;2M concentrate from human serum</title>
<p>Whole blood (13&#xa0;ml) was collected in a coagulation tube (BD Vacutainer SSTTM II,United States ) and centrifuged at 2,000 &#xd7; g for 20&#xa0;min to obtain 6&#xa0;ml of serum, which was then added to the upper filter of the ultrafiltration tube (Cytonics Corporation, West Palm Beach, Florida, United States ). The upper concentrate was obtained under different conditions of centrifugal force (3,000, 4,000, and 5,000 &#xd7; <italic>g</italic>) and time (20, 30, and 40&#xa0;min). Finally, the best concentration conditions were determined based on the concentration of &#x3b1;2M in the upper concentrate.</p>
</sec>
<sec id="s2-4">
<title>Human chondrocyte isolation and primary culture</title>
<p>Human chondrocytes were isolated as previously described (<xref ref-type="bibr" rid="B8">Guo et al., 2019</xref>) and plated in 6-well culture plates at a density of 1 &#xd7; 10<sup>6</sup> cells/plate. Chondrocytes culture medium was Dulbecco&#x2019;s Modified Eagle Medium/Nutrient Mixture F-12 (DMEM/F-12) containing 10% fetal bovine serum (Hyclone) At 90% confluence, the cells were cultured overnight under serum-free conditions and then treated with 10&#xa0;ng/ml recombinant human interleukin (IL)-1&#x3b2; for 2&#xa0;h before treatment with &#x3b1;2MRS. It was ensured that the concentration of &#x3b1;2M was 0.25&#xa0;mg/ml in the culture medium. The culture medium and chondrocytes were collected and analyzed.</p>
</sec>
<sec id="s2-5">
<title>Elisa assays</title>
<p>&#x3b1;2M concentrations in the upper concentrate under different centrifugal conditions were determined using ELISA (EK1118, Boster Bio, China). The human chondrocyte culture medium was collected 24&#xa0;h after &#x3b1;2MRS treatment and analyzed for the presence of MMP-13, tumor necrosis factor-&#x3b1; (TNF-&#x3b1;), and IL-6 using ELISA.</p>
</sec>
<sec id="s2-6">
<title>Human chondrocyte proliferation and apoptosis assays</title>
<p>Human chondrocyte proliferation was detected at 0, 24, 36, and 48&#xa0;h using the Cell Counting Kit-8 (CCK-8) cell viability assay kit (Boster Biological Technology, China). Human chondrocytes were collected 24&#xa0;h after &#x3b1;2MRS treatment and apoptosis was detected using a Terminal transferase dUTP end Labeling (TUNEL) assay kit (Key GEN Bio TECH, China). The percentage of positive cells was determined. The detailed procedure was in accordance with the manufacturer&#x2019;s protocol.</p>
</sec>
<sec id="s2-7">
<title>RNA isolation and real-time PCR assays</title>
<p>mRNA levels of <italic>col-2, aggrecan, MMP-3</italic>, and <italic>MMP-13</italic> in human chondrocyte samples and those plus <italic>collagen-10 a1 (col-10 a1)</italic> and <italic>Runx-2</italic> in minipig cartilage weight-bearing sites of the medial tibial plateau were measured by real-time PCR. Primer pairs are listed in <xref ref-type="sec" rid="s11">Supplementary Table S1</xref>. Levels of gene expression were normalized to 18S rRNA expression. The data were analyzed using the comparison Ct (2<sup>&#x2212;&#x394;&#x394;Ct</sup>) method and expressed as the fold-change relative to the respective control. The detailed PCR procedure was described previously (<xref ref-type="bibr" rid="B7">Gu et al., 2019</xref>).</p>
</sec>
<sec id="s2-8">
<title>Idealized ACL autograft reconstruction surgery</title>
<p>Eighteen mature female mini pigs (age, 18 &#xb1; 1.55&#xa0;months; weight, 43.3 &#xb1; 3.67&#xa0;kg) were randomized into three groups based on animal ear numbers: sham (<italic>n</italic> &#x3d; 6), IACL-R (<italic>n</italic> &#x3d; 6), and IACL-R&#x2b;&#x3b1;2MRS (<italic>n</italic> &#x3d; 6). All surgeries were performed under anesthesia via an intramuscular injection of 25&#xa0;mg/ml tiletamine and 25&#xa0;mg/ml zolazepam (Zoletil 50, 1 ml/15&#xa0;kg; Virbac Group, Carros, France). Unilateral surgery was performed on the right hind limbs of all mini pigs. Mini pigs in the IACL-R and IACL-R&#x2b;&#x3b1;2MRS groups were subjected to surgery based on methods described previously (<xref ref-type="fig" rid="F1">Figure 1</xref>; <xref ref-type="bibr" rid="B3">Bryan et al., 2011</xref>; <xref ref-type="bibr" rid="B9">Han et al., 2018</xref>). The minipigs in the sham group underwent arthrotomy, temporary patellar dislocation, and coring of one-third of the length of the lateral femoral condyle. Specific information on animal care can be found in the <xref ref-type="sec" rid="s11">Supplementary Text S1</xref>.</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>The surgical procedure performed on the right hind limb of a minipig in the IACL-R and IACL-R&#x2b;&#x3b1;2MRS groups. <bold>(A)</bold> The stifle joint was open and the patella was dislocated to expose the ACL (arrow). <bold>(B)</bold> The ACL reconstruction guide was positioned at a 45&#xb0; angle (arrow) to the longitudinal axis of the femur. <bold>(C)</bold> Before the hollow drill was about to penetrate the femoral tunnel, a Kirschner wire (diameter 1&#xa0;mm) was drilled along outer edge of the tunnel to prevent the cartilage from splitting. <bold>(D)</bold> The tunnel was gently penetrated by the same diameter thin-walled ring osteotomy to completely severv tendon-bone segment <bold>(E)</bold> The tendon-bone segment was completely freed (arrow). <bold>(F)</bold> The tendon-bone segment was fixed <italic>in situ</italic> with two crossed Kirschner wires.</p>
</caption>
<graphic xlink:href="fphar-13-849102-g001.tif"/>
</fig>
</sec>
<sec id="s2-9">
<title>Mini pig &#x3b1;2MRS reserve</title>
<p>With the help of a veterinarian, 120&#xa0;ml of whole blood was collected from the anterior vena cava of each mini pig into coagulation tubes before IACL-R. According to the best concentration conditions (centrifugal force: 5,000 &#xd7; <italic>g</italic>; time: 30&#xa0;min), 12&#x2013;15&#xa0;ml of &#x3b1;2MRS was obtained per mini pig (marked according to the mini pig ear number), and these samples were frozen at &#x2212;80&#xb0;C.</p>
</sec>
<sec id="s2-10">
<title>Synovial fluid collection</title>
<p>Synovial fluid from the right hind limbs of all animals was collected preoperatively (day 0) and postoperatively on days 3, 6, 14, 29, and 90. The detailed procedure was described previously (<xref ref-type="bibr" rid="B35">Wei et al., 2010</xref>).</p>
</sec>
<sec id="s2-11">
<title>Intra-articular injections</title>
<p>Under general anesthesia, intra-articular injections were administered 2, 6, 14, and 29&#xa0;days post-surgery using a sterile syringe. Under aseptic conditions, 2.5&#xa0;ml autologous &#x3b1;2MRS was injected into the right hind limbs of mini pigs in the IACL-R&#x2b;&#x3b1;2MRS group on the indicated days. Animals in the sham and IACL-R groups were administered an equivalent volume of saline.</p>
</sec>
<sec id="s2-12">
<title>Luminex assay</title>
<p>The Millipore Porcine Cytokine Magnetic Bead Panel (EMD Millipore, No. PCYTMAG-23K) was used to measure the levels of IL-1&#x3b1;, IL-1&#x3b2;, IL-2, IL-6, IL-8, IL-18, TNF-&#x3b1;, and granulocyte-macrophage colony-stimulating factor (GM-CSF). Luminex assays were performed as previously described (<xref ref-type="bibr" rid="B9">Han et al., 2018</xref>).</p>
</sec>
<sec id="s2-13">
<title>Gait assessment</title>
<p>Six gait indicators related to biomechanics&#x2014;maximum force, contact area, peak force, impulse, stance time, and swing time&#x2014;were determined using the Tekscan Walkway system (Tekscan Inc., United States ) (<xref ref-type="bibr" rid="B27">Rashid et al., 2013</xref>; <xref ref-type="bibr" rid="B31">Shah et al., 2020</xref>). To rule out individual differences in learning skills and walking states, each animal was subjected to over ten successful training sessions per day for ten consecutive days before the surgery, and all indicators were expressed as the ratio of the average values for the left hind limb divided by the average values for the right hind limb (<xref ref-type="bibr" rid="B29">Ruan et al., 2013</xref>). Gait data were collected preoperatively (day 0) and postoperatively on days 7, 15, 30, 45, 60, 75, and 90. All results obtained were the average of five successful repeated walkway trials performed at each time point for each animal.</p>
</sec>
<sec id="s2-14">
<title>Imaging assessment</title>
<p>Three months after the surgery, the mini pigs were euthanized with a pentobarbital overdose, and their right hind limbs were severed from the hip joint. Each right hind limb semi flexed was immediately subjected to X-ray examination, computed tomography (CT), three-dimensional CT reconstruction (3D CT), and magnetic resonance imaging (MRI). The specific imaging parameters are listed in <xref ref-type="sec" rid="s11">Supplementary Text S2</xref>.</p>
<p>We determined the Kellgren-Lawrence grade of the right hind limb of each animal by examining the X-ray image (<xref ref-type="bibr" rid="B14">Kellgren and Lawrence, 1957</xref>; <xref ref-type="bibr" rid="B21">Misir et al., 2020</xref>). The CT values and thickness of the subchondral bone plate were determined (<xref ref-type="bibr" rid="B12">Hu et al., 2020</xref>). To avoid interference by metal artifacts, we obtained CT scans of only the middle sagittal plane from the medial femoral condyle and medial tibial plateau of the right hind limb. We also determined the whole-organ MRI score (WORMS) of the medial femoral condyle and medial tibial plateau of the right hind limb (<xref ref-type="bibr" rid="B26">Pozzi et al., 2015</xref>; <xref ref-type="bibr" rid="B36">Xue et al., 2021</xref>).</p>
</sec>
<sec id="s2-15">
<title>Macroscopic cartilage and osteophyte assessment</title>
<p>Macroscopic damage to the articular cartilage surfaces and osteophyte formation on the medial femoral condyle, medial tibial plateau, lateral femoral condyle, lateral tibial plateau, and trochlea were scored according to the Osteoarthritis Research Society International (OARSI) recommendations for sheep and goats (<xref ref-type="bibr" rid="B19">Little et al., 2010</xref>)</p>
</sec>
<sec id="s2-16">
<title>Histological assessment</title>
<p>Cartilage samples were obtained by drilling (&#x3c6;8 mm; MOC Medizinische Ger&#xe4;te Gmbh, Fedderingen, Germany) the weight bearing site of the medial femoral condyle. The cartilage tissue sections (6&#xa0;&#xb5;m) were stained with safranin O and fast green as previously described and scored according to the recommendations of OARSI (<xref ref-type="bibr" rid="B19">Little et al., 2010</xref>). Furthermore, we collected synovium samples from inside the joint capsule. Synovium sections (4&#xa0;&#xb5;m) were stained with hematoxylin and eosin (H&#x26;E) as previously described and scored according to the OARSI recommendations (<xref ref-type="bibr" rid="B19">Little et al., 2010</xref>). Vertical meniscus slices from the middle region of the medial meniscus were processed and stained using H&#x26;E and scored according to the protocol detailed by <xref ref-type="bibr" rid="B25">Pauli et al. (2011)</xref>.</p>
</sec>
<sec id="s2-17">
<title>Immunohistochemical assessment</title>
<p>Immunohistochemical analysis was conducted as reported previously (<xref ref-type="bibr" rid="B16">Li et al., 2020</xref>). Briefly, to detect the distribution of the target protein, 6-&#x3bc;m thick cartilage tissue sections from the medial femoral condyle were collected on positively-charged glass slides. Endogenous peroxidase was blocked by treating the sections with 3% hydrogen peroxide in methanol. The sections were incubated with specific antibodies against Col-2 (1:500), MMP-3 (1:200), MMP-9 (1:100), MMP-13 (1:100), Col-10 (1:50), and Runx-2 (1:50) at 4&#xa0;&#xb0;C overnight. Thereafter, the sections were treated sequentially with a biotinylated secondary antibody and streptavidin&#x2013;peroxidase conjugate and then developed with 3,3&#x2032;-diaminobenzidine chromogen. Quantitative immunohistochemical analysis was performed using an imaging analyzer.</p>
</sec>
<sec id="s2-18">
<title>Statistical analysis</title>
<p>The SPSS statistical software (version 13.0) was used to analyze the collected data. Differences in gaits and inflammatory factor levels between the preoperative (day 0) and postoperative time points in the same group were analyzed using multiple comparisons of repeated measurement data. Differences in human chondrocytes, minipig gait, inflammatory factor levels, CT values, thicknesses of the subchondral bone plate T2 values, and quantitative immunohistochemical analysis at the same time point among the different groups were estimated using one-way analysis of variance. Differences in macroscopic cartilage and osteophyte scores; microscopic cartilage, synovium, and meniscus scores; and WORMS were estimated using nonparametric tests (Wilcoxon rank-sum test). Differences in Kellgren-Lawrence grades were estimated using Fisher probabilities. Statistical significance was set at <italic>p</italic> &#x3c; 0.05.</p>
</sec>
</sec>
<sec sec-type="results" id="s3">
<title>Results</title>
<p>All animals recovered from anesthesia and were fully awake within 3-5&#xa0;h after the surgery. There were no instances of infection or immune rejections.</p>
<sec id="s3-1">
<title>Concentration analysis of &#x3b1;2M in different concentrates from human and mini pig</title>
<p>As the centrifugal force increased and centrifugation time was prolonged, human &#x3b1;2M concentrations in the upper concentrate increased correspondingly (<xref ref-type="table" rid="T1">Table 1</xref>). Considering different factors, such as protein biological activity and concentrate volume, the concentration effect of &#x3b1;2M under the conditions of centrifugation at 5,000 <italic>g</italic> for 30&#xa0;min was ideal. For human &#x3b1;2MRS, the concentration of &#x3b1;2M was 11.13&#xa0;mg/ml, which was 4.88-fold higher than that in normal human serum. In mini pigs, the concentration of &#x3b1;2M was 12.32&#xa0;mg/ml, which was 6.48-fold higher than that in normal pig serum (<xref ref-type="fig" rid="F2">Figure 2A</xref>).</p>
<table-wrap id="T1" position="float">
<label>TABLE 1</label>
<caption>
<p>Human &#x3b1;2M concentrations in the upper concentrate under different centrifugal conditions (mg/ml) (Mean &#xb1; SD, <italic>n</italic> &#x3d; 6).</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="left"/>
<th align="center">3,000 &#xd7; <italic>g</italic>
</th>
<th align="center">4,000 &#xd7; <italic>g</italic>
</th>
<th align="center">5,000 &#xd7; <italic>g</italic>
</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">20min</td>
<td align="char" char="plusmn">4.82 &#xb1; 0.75</td>
<td align="char" char="plusmn">6.98 &#xb1; 1.15</td>
<td align="char" char="plusmn">8.23 &#xb1; 1.12</td>
</tr>
<tr>
<td align="left">30min</td>
<td align="char" char="plusmn">6.46 &#xb1; 0.89</td>
<td align="char" char="plusmn">9.22 &#xb1; 1.08</td>
<td align="char" char="plusmn">11.13 &#xb1; 0.90</td>
</tr>
<tr>
<td align="left">40min</td>
<td align="char" char="plusmn">7.39 &#xb1; 0.98</td>
<td align="char" char="plusmn">9.92 &#xb1; 1.17</td>
<td align="char" char="plusmn">11.93 &#xb1; 1.53</td>
</tr>
</tbody>
</table>
</table-wrap>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>
<bold>(A)</bold>. Human and mini pig &#x3b1;2M concentrations after centrifugation at 5,000 <italic>g</italic> for 30&#xa0;min. Human: serum: 2.28 &#xb1; 0.26&#xa0;mg/ml; upper concentrate: 11.13 &#xb1; 0.90&#xa0;mg/ml; filtration fluid: 0.000049 &#xb1; 0.00001&#xa0;mg/ml; mini pigs: serum: 1.90 &#xb1; 0.46&#xa0;mg/ml; upper concentrate: 12.32 &#xb1; 1.97&#xa0;mg/ml; filtration fluid: 0.000053 &#xb1; 0.000008&#xa0;mg/ml. <bold>(B&#x2013;D)</bold>. &#x3b1;2MRS significantly inhibited the induction of MMP-13,TNF-&#x3b1; and IL-6 in IL-1&#x3b2; induced human primary osteoarthritic chondrocytes. <bold>(E)</bold> The CCK-8 assay results showed that the viability of chondrocytes was higher in IL-1&#x3b2;&#x2b;&#x3b1;2MRS group relative to that in the IL-1&#x3b2; group, and the viability gradually increased with a longer treatment time. <bold>(F)</bold> TUNEL assay results showed that apoptosis (red) was reduced in the IL-1&#x3b2;&#x2b;&#x3b1;2MRS group seem to that in the IL-1&#x3b2; group. The bottom panels are higher-magnification views of the boxed areas in the top panels <bold>(G)</bold> The percentage of TUNEL-positive cells was quantified, and the apoptosis rate of chondrocytes was significantly reduced in the IL-1&#x3b2;&#x2b;&#x3b1;2MRS group relative to that in the IL-1&#x3b2; group. &#x2a; &#x3d; <italic>p</italic> &#x3c; 0.05, control group versus IL-1&#x3b2; group; &#x23; &#x3d; <italic>p</italic> &#x3c; 0.05, control group versus IL-1&#x3b2;&#x2b;&#x3b1;2MRS group; and &#x3d; <italic>p</italic> &#x3c; 0.05, IL-1&#x3b2; group versus IL-1&#x3b2;&#x2b;&#x3b1;2MRS group. The bars show the mean &#xb1; SD (<italic>n</italic> &#x3d; 6).</p>
</caption>
<graphic xlink:href="fphar-13-849102-g002.tif"/>
</fig>
</sec>
<sec id="s3-2">
<title>Human chondrocyte culture medium analysis</title>
<p>ELISA results demonstrated that exogenous &#x3b1;2MRS significantly inhibited the induction of MMP-13 (<italic>p</italic> &#x3d; 0.001), TNF-&#x3b1; (<italic>p</italic> &#x3d; 0.005), and IL-6 (<italic>p</italic> &#x3c; 0.001) activity in IL-1&#x3b2;-induced human primary osteoarthritis chondrocytes (<xref ref-type="fig" rid="F2">Figures 2B&#x2013;D</xref>).</p>
</sec>
<sec id="s3-3">
<title>Human chondrocyte proliferation and apoptosis analysis</title>
<p>&#x3b1;2MRS promoted the proliferation and reduced the apoptosis of human chondrocytes <italic>in vitro.</italic> The results of the CCK-8 assay showed that the viability of chondrocytes was higher in the IL-1&#x3b2;&#x2b;&#x3b1;2MRS group than in the IL-1&#x3b2; group (<italic>p</italic> &#x3c; 0.001), and the viability gradually increased with treatment time (<xref ref-type="fig" rid="F2">Figure 2E</xref>). The results of the TUNEL assay showed that apoptosis was significantly reduced in the IL-1&#x3b2;&#x2b;&#x3b1;2MRS group (18.33% &#xb1; 5.71%) relative to that in the IL-1&#x3b2; group (32.33% &#xb1; 7.23%; <italic>p</italic> &#x3c; 0.001; <xref ref-type="fig" rid="F2">Figures 2F,G</xref>).</p>
</sec>
<sec id="s3-4">
<title>Real-time PCR analysis</title>
<p>Real-time PCR data indicated that supplementation with &#x3b1;2MRS reduced cartilage matrix catabolism and enhanced anabolic metabolism <italic>in vitro</italic> (<xref ref-type="fig" rid="F3">Figures 3A&#x2013;D</xref>) and <italic>in vivo</italic> (<xref ref-type="fig" rid="F3">Figures 3E&#x2013;J</xref>). mRNA levels of <italic>MMP-3</italic> (<italic>p</italic> &#x3c; 0.001), <italic>MMP-13</italic> (<italic>p</italic> &#x3c; 0.001), <italic>Col-10 a1</italic> (<italic>p</italic> &#x3d; 0.001), and <italic>Runx-2</italic> (<italic>p</italic> &#x3c; 0.001) were lower in the IL-1&#x3b2;&#x2b;&#x3b1;2MRS and IACL-R&#x2b;&#x3b1;2MRS groups than in the IL-1&#x3b2; and IACL-R groups. In contrast, mRNA levels of <italic>Col-2</italic> (<italic>p</italic> &#x3c; 0.001) and <italic>aggrecan</italic> (<italic>p</italic> &#x3c; 0.001) showed the opposite pattern. Both were increased in the IL-1&#x3b2;&#x2b;&#x3b1;2MRS and IACL-R&#x2b;&#x3b1;2MRS groups as compared to the levels in the IL-1&#x3b2; and IACL-R groups, respectively.</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>Real-time PCR data indicated that supplementation with &#x3b1;2MRS reduced cartilage matrix catabolism and enhanced anabolism <italic>in-vitro</italic> <bold>(A&#x2013;D)</bold> and <italic>in-vivo</italic> <bold>(E&#x2013;J)</bold>. mRNA levels of <italic>MMP-3</italic> (<italic>p</italic> &#x3c; 0.001), <italic>MMP-13</italic> (<italic>p</italic> &#x3c; 0.001), <italic>Col-10</italic> a1 (<italic>p</italic> &#x3d; 0.001), and <italic>Runx-2</italic> (<italic>p</italic> &#x3c; 0.001)were lower in IL-1&#x3b2;&#x2b;&#x3b1;2MRS and IACL-R&#x2b;&#x3b1;2MRS groups than in IL-1&#x3b2; and IACL-R groups respectively. In contrast, mRNA levels of <italic>Col-2</italic> (<italic>p</italic> &#x3c; 0.001) and <italic>aggrecan</italic> (<italic>p</italic> &#x3c; 0.001) followed the opposite pattern. Both were increased in IL-1&#x3b2;&#x2b;&#x3b1;2MRS and IACL-R&#x2b;&#x3b1;2MRS groups as compared to levels in IL-1&#x3b2; and IACL-R groups. &#x2a; &#x3d; <italic>p</italic> &#x3c; 0.05, control group versus IL-1&#x3b2; group or sham group versus IACL-R group; &#x23; &#x3d; <italic>p</italic> &#x3c; 0.05, control group versus IL-1&#x3b2;&#x2b;&#x3b1;2MRS group or sham group versus IACL-R&#x2b;&#x3b1;2MRS group; and &#x3d; <italic>p</italic> &#x3c; 0.05, IL-1&#x3b2; group versus IL-1&#x3b2;&#x2b;&#x3b1;2MRS group or IACL-R group versus IACL-R&#x2b;&#x3b1;2MRS group. The bars show the mean &#xb1; SD (<italic>n</italic> &#x3d; 6).</p>
</caption>
<graphic xlink:href="fphar-13-849102-g003.tif"/>
</fig>
</sec>
<sec id="s3-5">
<title>Inflammatory factor analysis</title>
<p>Postoperatively, changes in the levels of inflammatory factors in different groups, except for IL-18 in the IACL-R group, showed similar trends; the levels markedly increased in the early stage and then decreased significantly. The IL-2 concentration in the IACL-R group subsequently showed an increasing trend from day 30 to day 90. The concentrations of inflammatory factors, including IL-1&#x3b2;, IL-6, IL-18, TNF-&#x3b1;, and GM-CSF, in the IACL-R and IACL-R&#x2b;&#x3b1;2MRS groups after surgery were significantly higher than those before surgery (<italic>p</italic> &#x3c; 0.001). The concentration of all tested inflammatory factors other than IL-1&#x3b1; after surgery was significantly lower in the IACL-R&#x2b;&#x3b1;2MRS group than in the IACL-R group, and a significant difference in peak concentrations was observed in all factors (<italic>p</italic> &#x3c; 0.001). Moreover, the peak concentrations of all detected inflammatory factors, other than IL-18 in the IACL-R group, appeared within 3&#x2013;14 days after surgery (<xref ref-type="fig" rid="F4">Figure 4</xref>).</p>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption>
<p>Line charts of inflammatory factors in synovial fluid. <bold>(A)</bold>: IL-1&#x3b1;; <bold>(B)</bold> IL-1&#x3b2;; <bold>(C)</bold> IL-2; <bold>(D)</bold> IL-6; <bold>(E)</bold> IL-8; <bold>(F)</bold> IL-18; <bold>(G)</bold> TNF-&#x3b1;; <bold>(H)</bold> GM-CSF. &#x2a; &#x3d; <italic>p</italic> &#x3c; 0.05, sham group versus IACL-R group at the same time point; &#x23; &#x3d; <italic>p</italic> &#x3c; 0.05, sham group versus IACL-R&#x2b;&#x3b1;2MRS group at the same time point; and &#x3d; <italic>p</italic> &#x3c; 0.05, IACL-R group versus IACL-R&#x2b;&#x3b1;2MRS group at the same time point. a &#x3d; <italic>p</italic> &#x3c; 0.05, preoperative (day 0) versus postoperative (days 3, 6, 14, 29, and 90) in the sham group; b &#x3d; <italic>p</italic> &#x3c; 0.05, preoperative (day 0) versus postoperative (days 3, 6, 14, 29, and 90) in the IACL-R group; c &#x3d; <italic>p</italic> &#x3c; 0.05, preoperative (day 0) versus postoperative (days 3, 6, 14, 29, and 90) in the IACL-R&#x2b;&#x3b1;2MRS group. The bars show the mean &#xb1; SD (n &#x3d; 6)</p>
</caption>
<graphic xlink:href="fphar-13-849102-g004.tif"/>
</fig>
</sec>
<sec id="s3-6">
<title>Gait assessment</title>
<p>Across all groups, the ratios of all gait parameters of the left hind limb to those of the right hind limb initially showed an increasing trend, followed by a decreasing trend, except in the IACL-R group, which showed another increasing trend toward the end. In the IACL-R group, no gait parameters, from day 45 until day 75, differed significantly from those on day 0 (<italic>p</italic> &#x3e; 0.05). In the IACL-R&#x2b;&#x3b1;2MRS group, no gait parameters, from day 30 until euthanasia, differed significantly from those on day 0 (<italic>p</italic> &#x3e; 0.05) (<xref ref-type="fig" rid="F5">Figure 5</xref>).</p>
<fig id="F5" position="float">
<label>FIGURE 5</label>
<caption>
<p>Line charts of gait analysis. <bold>(A)</bold>Maximum force; <bold>(B)</bold>Contact area; <bold>(C)</bold>Peak force; <bold>(D)</bold>Impulse; <bold>(E)</bold>Stance time; <bold>(F)</bold> Swing time. &#x2a; &#x3d; <italic>p</italic> &#x3c; 0.05, sham group versus IACL-R group at the same time point; &#x23; &#x3d; <italic>p</italic> &#x3c; 0.05, sham group versus IACL-R&#x2b;&#x3b1;2MRS group at the same time point; and &#x3d; <italic>p</italic> &#x3c; 0.05, IACL-R group versus IACL-R&#x2b;&#x3b1;2MRS group at the same time point. a &#x3d; <italic>p</italic> &#x3c; 0.05, preoperative (day 0) versus postoperative (days 7, 15, 30, 45, 60, 75, and 90) in the sham group; b &#x3d; <italic>p</italic> &#x3c; 0.05, preoperative (day 0) versus postoperative (days 7, 15, 30, 45, 60, 75, and 90) in the IACL-R group; c &#x3d; <italic>p</italic> &#x3c; 0.05, preoperative (day 0) versus postoperative (days 7, 15, 30, 45, 60, 75, and 90) in the IACL-R&#x2b;&#x3b1;2MRS group. The bars show the mean &#xb1; SD (n &#x3d; 6)</p>
</caption>
<graphic xlink:href="fphar-13-849102-g005.tif"/>
</fig>
<p>The ratios of the left hind limb to the right hind limb of all gait parameters were similar and close to one for symmetry and did not differ significantly in all groups before surgery (<italic>p</italic> &#x3e; 0.05). Meanwhile, the postoperative ratios of the left hind limb to the right hind limb of the gait parameters were significantly greater than one in all groups, and the values in the IACL-R group were significantly greater than those in the other two groups other than swing time, especially on days 7 and 15 (<italic>p</italic> &#x3c; 0.001). The ratios of the left hind limb to the right hind limb of the gait parameters were close to one on days 45 and 60, indicating that there were no significant differences among the groups (<italic>p</italic> &#x3e; 0.05). On day 75, this ratio increased only in the IACL-R group whereas it remained constant in the sham and IACL-R&#x2b;&#x3b1;2MRS groups. On day 90, all gait parameters other than swing time (<italic>p</italic> &#x3d; 0.345) significantly differed between the IACL-R group and the other two groups (<italic>p</italic> &#x3c; 0.001; <xref ref-type="fig" rid="F5">Figure 5</xref>).</p>
</sec>
<sec id="s3-7">
<title>Imaging assessment</title>
<p>The X-ray examinations showed that joint degeneration in the IACL-R group was relatively noticeable. The joints had a blurred border and mild osteophyte formation compared with those in the IACL-R&#x2b;&#x3b1;2MRS group (<xref ref-type="fig" rid="F6">Figure 6A</xref>). The Kellgren-Lawrence grades did not significantly differ among the three groups (<italic>p</italic> &#x3e; 0.05; <xref ref-type="table" rid="T2">Table 2</xref>). Three-dimensional CT reconstruction showed that all joint surfaces were relatively smooth and flat in the IACL-R&#x2b;&#x3b1;2MRS group compared to the IACL-R group. Osteophyte was seen on both sides of the patellofemoral joint in the IACL-R group (<xref ref-type="fig" rid="F6">Figure 6B</xref>). Both the medial femoral condyle (<italic>p</italic> &#x3c; 0.001) and medial tibial plateau (<italic>p</italic> &#x3c; 0.001) showed significant differences in CT values in the subchondral bone plate between the sham and IACL-R groups. In addition, significant differences in CT values were found between the IACL-R&#x2b;&#x3b1;2MRS and IACL-R groups in the medial femoral condyle (<italic>p</italic> &#x3d; 0.028; <xref ref-type="fig" rid="F6">Figure 6D</xref>). Significant differences in the thickness of the subchondral bone plate were found only between the sham and IACL-R groups in the medial tibial plateau (<italic>p</italic> &#x3d; 0.020; <xref ref-type="fig" rid="F6">Figure 6E</xref>). MRI OSag-fs PD showed that cartilage continuity was better without obvious local defects in the IACL-R&#x2b;&#x3b1;2MRS group than in the IACL-R group (<xref ref-type="fig" rid="F6">Figure 6C</xref>, left). WORMS of the medial femoral condyle (<italic>p</italic> &#x3d; 0.006), medial tibial plateau (<italic>p</italic> &#x3d; 0.014), and sum (<italic>p</italic> &#x3d; 0.004) were significantly lower in the IACL-R&#x2b;&#x3b1;2MRS group than in the IACL-R group (<xref ref-type="fig" rid="F6">Figures 6G&#x2013;I</xref>; <xref ref-type="sec" rid="s11">Supplementary Table S2</xref>). Osag T2MAP showed that regular orange-red layers were more obvious in the IACL-R&#x2b;&#x3b1;2MRS group than in the IACL-R group (<xref ref-type="fig" rid="F6">Figure 6C</xref>, right). The T2 values of the medial femoral condyle (<italic>p</italic> &#x3c; 0.001) and medial tibial plateau (<italic>p</italic> &#x3c; 0.001) were significantly lower in the IACL-R&#x2b;&#x3b1;2MRS group than in the IACL-R group (<xref ref-type="fig" rid="F6">Figure 6F</xref>).</p>
<fig id="F6" position="float">
<label>FIGURE 6</label>
<caption>
<p>Imaging assessments <bold>(A)</bold>: X-ray examination;(<bold>B)</bold>: three-dimensional CT reconstruction;(<bold>C)</bold>: MRI examination (left: Osag fs PD; right: Osag T2MAP). <bold>(D)</bold>: The CT values of the subchondral bone plate. sham group (medial femoral condyle, 724.2 &#xb1; 62.95; medial tibial plateau, 830.3 &#xb1; 71.26); IACL-R group (medial femoral condyle, 517.7 &#xb1; 83.89; medial tibial plateau, 621.2 &#xb1; 83.57); IACL-R&#x2b;&#x3b1;2MRS group (medial femoral condyle, 630 &#xb1; 66.9; medial tibial plateau, 719.2 &#xb1; 76.73). <bold>(E)</bold>: The thickness of the subchondral bone plate. sham group (medial femoral condyle, 1.46 &#xb1; 0.14; medial tibial plateau, 1.72 &#xb1; 0.19); IACL-R group (medial femoral condyle, 1.25 &#xb1; 0.19; medial tibial plateau, 1.41 &#xb1; 0.20); IACL-R&#x2b;&#x3b1;2MRS group (medial femoral condyle, 1.35 &#xb1; 0.24; medial tibial plateau, 1.54 &#xb1; 0.19). <bold>(F)</bold>: Quantification of the T2 values obtained using MRI sag T2MAP.Sham group (medial femoral condyle, 39.5 &#xb1; 3.62; medial tibial plateau, 42 &#xb1; 3.41); IACL-R group (medial femoral condyle, 62 &#xb1; 4.78; medial tibial plateau, 57 &#xb1; 3.58); IACL-R&#x2b;&#x3b1;2MRS group (medial femoral condyle, 48.67 &#xb1; 3.45; medial tibial plateau, 48.17 &#xb1; 1.94). <bold>(G&#x2013;I)</bold>: Quantification of the MRI OSag fs PD results using the WORMS guidelines. The white arrows indicate irregularities, osteophytes, and cartilage defects. &#x2a; &#x3d; <italic>p</italic> &#x3c; 0.05, sham group versus IACL-R group; &#x23; &#x3d; <italic>p</italic> &#x3c; 0.05, sham group versus IACL-R&#x2b;&#x3b1;2MRS group; and &#x3d; <italic>p</italic> &#x3c; 0.05, IACL-R group versus IACL-R&#x2b;&#x3b1;2MRS group. The bars show the mean &#xb1; SD (<italic>n</italic> &#x3d; 6).</p>
</caption>
<graphic xlink:href="fphar-13-849102-g006.tif"/>
</fig>
<table-wrap id="T2" position="float">
<label>TABLE 2</label>
<caption>
<p>Kellgren-Lawrence grades on X-ray examination at 3 months (<italic>n</italic> &#x3d; 6).</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="left">Group</th>
<th align="left">Grade 0</th>
<th align="left">Grade 1</th>
<th align="left">Grade 2</th>
<th align="left">Grade 3</th>
<th align="left">Grade 4</th>
<th align="left">P</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">sham</td>
<td align="left" char=".">3</td>
<td align="left" char=".">2</td>
<td align="left" char=".">1</td>
<td align="left" char=".">0</td>
<td align="left" char=".">0</td>
<td align="left"/>
</tr>
<tr>
<td align="left">IACL-R</td>
<td valign="top" align="left">0</td>
<td align="left" char=".">1</td>
<td align="left" char=".">3</td>
<td align="left" char=".">2</td>
<td align="left" char=".">0</td>
<td align="left" char=".">&#x3e;0.05</td>
</tr>
<tr>
<td align="left">IACL-R&#x2b;&#x3b1;2M</td>
<td valign="top" align="left">2</td>
<td align="left" char=".">3</td>
<td align="left" char=".">1</td>
<td align="left" char=".">0</td>
<td align="left" char=".">0</td>
<td align="left"/>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="s3-8">
<title>Macroscopic cartilage and osteophyte assessment</title>
<p>Compared to that in the IACL-R group, cartilage degeneration was relatively low and no obvious cartilage defects or large erosions were found in the IACL-R&#x2b;&#x3b1;2MRS group (<xref ref-type="fig" rid="F7">Figure 7A</xref>). OARSI scores of macroscopic cartilage were significantly lower in the IACL-R&#x2b;&#x3b1;2MRS group than in the IACL-R group (<italic>p</italic> &#x3d; 0.031; <xref ref-type="fig" rid="F7">Figure 7B</xref>; <xref ref-type="sec" rid="s11">Supplementary Figures S1A&#x2013;E</xref>; <xref ref-type="sec" rid="s11">Supplementary Table S2</xref>). Mild irregular protrusions were found only on sides of the trochlea in the IACL-R group (<xref ref-type="fig" rid="F7">Figure 7A</xref>). No differences were found in the OARSI sum scores of the osteophyte among the three groups (<italic>p</italic> &#x3d; 0.438; <xref ref-type="fig" rid="F7">Figure 7C</xref>; <xref ref-type="sec" rid="s11">Supplementary Figures S1F&#x2013;J</xref>; <xref ref-type="sec" rid="s11">Supplementary Table S2</xref>).</p>
<fig id="F7" position="float">
<label>FIGURE 7</label>
<caption>
<p>
<bold>(A)</bold>: Images of the trochlea, femoral condyle, and tibial plateau for the macroscopic cartilage and osteophyte assessment according to OARSI guidelines. The white arrows indicate cartilage damage, irregularities, and osteophytes. <bold>(B)</bold>: Macroscopic cartilage score were lower in the IACL-R&#x2b;&#x3b1;2MRS group than in the IACL-R group (<italic>p</italic> &#x3d; 0.031). <bold>(C)</bold>: Macroscopic osteophyte scores did not differ among the different groups (<italic>p</italic> &#x3d; 0.438). &#x2a; &#x3d; <italic>p</italic> &#x3c; 0.05, sham group versus IACL-R group; &#x23; &#x3d; <italic>p</italic> &#x3c; 0.05, sham group versus IACL-R&#x2b;&#x3b1;2MRS group; and &#x3d; <italic>p</italic> &#x3c; 0.05, IACL-R group versus IACL-R&#x2b;&#x3b1;2MRS group. The bars show the mean &#xb1; SD (<italic>n</italic> &#x3d; 6).</p>
</caption>
<graphic xlink:href="fphar-13-849102-g007.tif"/>
</fig>
</sec>
<sec id="s3-9">
<title>Histological assessment</title>
<p>Less decreases in safranin O staining and surface fibrillation were observed in the IACL-R&#x2b;&#x3b1;2MRS group as compared to the IACLR-group (<xref ref-type="fig" rid="F8">Figure 8A</xref>). The microscopic OARSI cartilage scores were lower in the IACL-R&#x2b;&#x3b1;2MRS group than in the IACL-R group (<italic>p</italic> &#x3d; 0.015; <xref ref-type="fig" rid="F8">Figure 8B</xref>; <xref ref-type="sec" rid="s11">Supplementary Figures 2A&#x2013;E</xref>; <xref ref-type="sec" rid="s11">Supplementary Table S2</xref>). Based on H&#x26;E staining of the synovium, we found mild intimal thickening, low inflammatory cell infiltration, and slight sub-intimal fibrosis and vascularity in the IACL-R&#x2b;&#x3b1;2MRS group, relative to those in the IACL-R group (<xref ref-type="fig" rid="F8">Figure 8C</xref>). Thus, the microscopic OARSI synovium scores, both total scores (<italic>p</italic> &#x3d; 0.002) and single indicator scores, showed that synovial damage was lower in the IACL-R&#x2b;&#x3b1;2MRS group than in the IACL-R group (<xref ref-type="fig" rid="F8">Figure 8D</xref>; <xref ref-type="sec" rid="s11">Supplementary Figures S2F&#x2013;I</xref>; <xref ref-type="sec" rid="s11">Supplementary Table S2</xref>). H&#x26;E staining of the meniscus also revealed mild surface fibrillation, normal cell distribution, and a normal collagen fiber organization (<xref ref-type="fig" rid="F8">Figure 8E</xref>), and the meniscus score was lower in the IACL-R&#x2b;&#x3b1;2MRS group than in the IACL-R group (<italic>p</italic> &#x3c; 0.001; <xref ref-type="fig" rid="F8">Figure 8F</xref>; <xref ref-type="sec" rid="s11">Supplementary Figures 2J&#x2013;L</xref>; <xref ref-type="sec" rid="s11">Supplementary Table S2</xref>).</p>
<fig id="F8" position="float">
<label>FIGURE 8</label>
<caption>
<p>
<bold>(A)</bold> Compared with the IACL-R group, less decrease in safranin O staining and surface fibrillation were observed in the IACL-R&#x2b;&#x3b1;2MRS group. <bold>(B)</bold> Microscopic cartilage score were lower in the IACL-R&#x2b;&#x3b1;2MRS group than in the IACL-R group (<italic>p</italic> &#x3d; 0.015). <bold>(C)</bold> On H&#x26;E staining of the synovium, we found less degeneration in the IACL-R&#x2b;&#x3b1;2MRS group than in the IACL-R group. <bold>(D)</bold> Microscopic synovium score were lower in the IACL-R&#x2b;&#x3b1;2MRS group than in the IACL-R group (<italic>p</italic> &#x3d; 0.002). <bold>(E)</bold> On H&#x26;E staining of the meniscus, we found less degeneration in the IACL-R&#x2b;&#x3b1;2MRS group than in the IACL-R group <bold>(F)</bold> Microscopic meniscus score were lower in the IACL-R&#x2b;&#x3b1;2MRS group than in the IACL-R group (<italic>p</italic> &#x3c; 0.001). &#x2a; &#x3d; <italic>p</italic> &#x3c; 0.05, sham group versus IACL-R group; &#x23; &#x3d; <italic>p</italic> &#x3c; 0.05, sham group versus IACL-R&#x2b;&#x3b1;2MRS group; and &#x3d; <italic>p</italic> &#x3c; 0.05, IACL-R group versus IACL-R&#x2b;&#x3b1;2MRS group. The bars show the mean &#xb1; SD (<italic>n</italic> &#x3d; 6).</p>
</caption>
<graphic xlink:href="fphar-13-849102-g008.tif"/>
</fig>
</sec>
<sec id="s3-10">
<title>Immunohistochemical assessment</title>
<p>Both articular cartilage (<xref ref-type="fig" rid="F9">Figures 9A,B</xref>) and synovium (<xref ref-type="fig" rid="F9">Figures 9C,D</xref>) immunostaining showed that MMP-3 (<italic>p</italic> &#x3c; 0.001), MMP-9 (<italic>p</italic> &#x3c; 0.001), MMP-13 (<italic>p</italic> &#x3c; 0.001), Col -10 (<italic>p</italic> &#x3c; 0.001), and Runx-2 (<italic>p</italic> &#x3d; 0.001) staining significantly increased in the IACL-R group compared with the IACL-R&#x2b;&#x3b1;2MRS group. In contrast, Col-2 (<italic>p</italic> &#x3c; 0.001) expression in articular cartilage was higher in the IACL-R&#x2b;&#x3b1;2MRS group than in the IACL-R group.</p>
<fig id="F9" position="float">
<label>FIGURE 9</label>
<caption>
<p>
<bold>(A)</bold>: Articular cartilage immunostaining showed that MMP-3, MMP-9, MMP-13, Runx-2, and Col -10 staining significantly increased in the IACL-R mini pig group but were lower in the IACL-R&#x2b;&#x3b1;2MRS group. In contrast, Col-2 expression in articular cartilage was higher in the IACL-R&#x2b;&#x3b1;2MRS group than in the IACL-R group. <bold>(B)</bold> Quantitative immunohistochemical analysis of articular cartilage. <bold>(C)</bold> synovium immunostaining showed that MMP-3, MMP-9 and MMP-13 staining significantly increased in the IACL-R mini pig group but were lower in the IACL-R&#x2b;&#x3b1;2MRS group. <bold>(D)</bold> Quantitative immunohistochemical analysis of synovium. &#x2a; &#x3d; <italic>p</italic> &#x3c; 0.05, sham group versus IACL-R group; &#x23; &#x3d; <italic>p</italic> &#x3c; 0.05, sham group versus IACL-R&#x2b;&#x3b1;2MRS group; and &#x3d; <italic>p</italic> &#x3c; 0.05, IACL-R group versus IACL-R&#x2b;&#x3b1;2MRS group. The bars show the mean &#xb1; SD (<italic>n</italic> &#x3d; 6).</p>
</caption>
<graphic xlink:href="fphar-13-849102-g009.tif"/>
</fig>
</sec>
</sec>
<sec sec-type="discussion" id="s4">
<title>Discussion</title>
<p>There are various conservative treatment methods for PTOA, including physical therapy, oral drugs, and intra-articular drug injection. Although physical therapy has the advantage of being non-invasive, it is mainly effective for patients with mild symptoms. Owing to the barrier function of the joint capsule, many oral drugs cannot enter the joint cavity to exert an effect. To date, intra-articular drug injection is the most effective method for the treatment of OA. &#x3b1;2M performs complex body functions, including the regulation of cytokine and hormone levels. It can bind several cytokines, including basic fibroblast growth factor, platelet-derived growth factor, nerve growth factor, IL-1&#x3b2;, and IL-6, and regulate the levels of hepcidin and leptin (<xref ref-type="bibr" rid="B28">Rehman et al., 2013</xref>). The specific mechanism of &#x3b1;2M has been previously reported by Sottrup-Jensen (<xref ref-type="bibr" rid="B32">Sottrup-Jensen 1989</xref>). Notably, recent studies showed that &#x3b1;2M can attenuate PTOA cartilage degeneration (<xref ref-type="bibr" rid="B34">Wang et al., 2014</xref>; <xref ref-type="bibr" rid="B37">Zhang et al., 2017</xref>; Li et al., 2019). However, &#x3b1;2M is not present in synovial fluid at sufficient levels due to its large molecular weight, which prevents its migration from the blood into the synovial fluid to counteract the increased concentrations of catabolic factors that appear after joint injury (<xref ref-type="bibr" rid="B30">Salvesen and Enghild, 1993</xref>). Thus, introducing supplemental &#x3b1;2M in the joint cavity might be a strategy to attenuate cartilage degeneration. However, considering the expense and potential safety concerns of biosynthetic &#x3b1;2M, &#x3b1;2MRS is a promising alternative for PTOA treatment. The results of our study demonstrate, for the first time, that &#x3b1;2MRS, as a master inhibitor of inflammatory factors, can attenuate cartilage degeneration <italic>in vitro</italic> and <italic>in vivo</italic>.</p>
<p>First, our <italic>in vitro</italic> data clearly demonstrated that human &#x3b1;2MRS promotes the proliferation of human chondrocyte, reduces the apoptosis of these, and decreases chondrocyte catabolic cytokine gene transcription and secretion, suggesting that &#x3b1;2MRS is a promising therapy. The ultimate goal of studying &#x3b1;2MRS is its clinical application. Thus, its biological safety and effectiveness need to be accurately evaluated and verified <italic>in-vivo</italic>.</p>
<p>Other studies have confirmed that significantly elevated inflammatory factors might be crucial for the pathogenesis of PTOA (<xref ref-type="bibr" rid="B20">Maerz et al., 2018</xref>; <xref ref-type="bibr" rid="B38">Zhao et al., 2021</xref>). There is a significant correlation between the expression of inflammatory factors, such as IL-1&#x3b2;, IL-6, and TNF-&#x3b1;, and cartilage injury (<xref ref-type="bibr" rid="B9">Han et al., 2018</xref>). Consistent with this, our findings demonstrated that different inflammatory factors exhibit different trends and could also play different pathogenic roles in the process of PTOA. Previous studies have demonstrated that the peak levels of cartilage catabolic enzymes could be detected on day 2 after joint injury (<xref ref-type="bibr" rid="B38">Zhao et al., 2021</xref>). Therefore, the mini pigs in the IACL-R&#x2b;&#x3b1;2MRS group received the first &#x3b1;2MRS joint cavity injection 2 days after surgery, which inhibited the levels of various inflammatory factors. Luminex results revealed that not only the peak concentrations of inflammatory factors in synovial fluid were significantly reduced but that the speed of decline was also faster in the IACL-R&#x2b;&#x3b1;2MRS group than in the IACL-R group, which demonstrated the early effect of &#x3b1;2MRS. In addition, gait analysis showed that the gait ratios of the left hind limb to the right hind limb of the IACL-R&#x2b;&#x3b1;2MRS group were significantly greater than one&#xa0;at 7 days post-surgery, but it was significantly lower than that in the IACL-R group, which further proves the effectiveness of &#x3b1;2MRS. Other research results suggest that the activity of some cartilage catabolic enzymes might have two peaks. The first phase appears after the initial trauma to the joint. The second peak is associated with progressive cartilage degeneration at weeks four and 6 after surgery. Therefore, we repeated &#x3b1;2MRS supplementation, which constantly exerts an inflammation-inhibitory effect, and the inflammatory storm or waterfall effect was interrupted in time (<xref ref-type="bibr" rid="B24">Pan et al., 2016</xref>). Therefore, in the later stage (days 30-90) of the experiment, the concentration of inflammatory factors in the synovial fluid in the IACL-R&#x2b;&#x3b1;2MRS group was maintained at a low level, and no obvious rebound was observed. Gait analysis is a relatively sensitive test for abnormal biomechanics and pain in the knee joint (<xref ref-type="bibr" rid="B23">Muramatsu et al., 2014</xref>; <xref ref-type="bibr" rid="B4">Capin et al., 2018</xref>; <xref ref-type="bibr" rid="B13">Hughes-Oliver et al., 2018</xref>). Compared with preoperative parameters, the gait of the IACL-R group also returned to initial levels, showing no significant difference in the middle stage (days 30-60). We conclude that the IACL-R model can restore the normal gait parameters of the knee joint and indirectly speculate that the ACL might have relatively stable biomechanical and consistent functions in different groups.</p>
<p>The mini pigs in the IACL-R&#x2b;&#x3b1;2MRS group received &#x3b1;2MRS joint cavity injection four times starting from day 2 after surgery, which resulted in long-lasting inflammation suppression, significantly slowing the degeneration of articular cartilage. Therefore, the final imaging assessment, macroscopic cartilage assessment, and microscopic histological analysis confirmed that the articular cartilage in the IACL-R&#x2b;&#x3b1;2MRS group was only slightly degenerated. Moreover, our biochemistry data demonstrated that supplemental &#x3b1;2MRS not only inhibited catabolic factors, including <italic>MMP-3, MMP-13, Col-10,</italic> and <italic>Runx-2</italic>, but also enhanced <italic>Col-2</italic> gene expression and protein synthesis. The increase in collagen suggests that &#x3b1;2MRS might have cartilage-repair functions. This finding is consistent with previous reports (<xref ref-type="bibr" rid="B37">Zhang et al., 2017</xref>). Moreover, the results of H&#x26;E staining of the synovium and meniscus proved that &#x3b1;2MRS injection into the joint cavity could significantly reduce inflammatory cell infiltration and vascularity, protecting the articular cartilage, synovium, and meniscus. Combining our results with those of other studies (Rehman, 2013), we speculate that &#x3b1;2MRS might act by binding cytokines, in addition to directly neutralizing enzyme activities, but the exact mechanism is not clear. The relative contributions of these mechanisms will be addressed in future studies.</p>
<p>Our study has a few limitations. First, the state of tension in the ACL or biomechanical changes in the knee joint post-surgery are crucial. To date, there is no technology or instrument that can accurately detect the smaller motions between the femur and tibia that are controlled by the ACL. The gait analysis used in this study can only roughly or indirectly assess the biomechanical stability of the knee joint. Second, although the concentration of &#x3b1;2M in &#x3b1;2MRS was 6.48-fold higher than that in normal mini pig serum, &#x3b1;2MRS is in fact a mixture containing extremely complex components. &#x3b1;2MRS was injected into the joint cavity, and proteins other than &#x3b1;2M might also play a role, but the exact mechanism is still unknown. Third, considering the side effects of the multiple anesthesia method used, we do not know the exact trend of inflammatory factor levels during the period from days 29&#x2013;90 after surgery.</p>
<p>In summary, &#x3b1;2MRS is a promising bioinhibitor of catabolic proteases, and early and multiple injections in the joint cavity after IACL-R can significantly reduce the concentration of inflammatory factors in the joint synovial fluid of mini pigs and the degeneration of articular cartilage, exerting a chondroprotective effect.</p>
</sec>
</body>
<back>
<sec sec-type="data-availability" id="s5">
<title>Data availability statement</title>
<p>The original contributions presented in the study are included in the article/<xref ref-type="sec" rid="s11">Supplementary Material</xref> further inquiries can be directed to the corresponding author.</p>
</sec>
<sec id="s6">
<title>Ethics statement</title>
<p>The studies involving human participants were reviewed and approved by the Ethics Committee of the Second Hospital of Shanxi Medical University. The patients/participants provided their written informed consent to participate in this study. The animal study was reviewed and approved by The Ethics Committee of the Second Hospital of Shanxi Medical University.</p>
</sec>
<sec id="s7">
<title>Author contributions</title>
<p>RZ and LH participated in the study design, wrote the manuscript, performed most of the experiments, and analyzed data. XW and LH conceived the study, revised the manuscript. CZ, HW, CX, WD, and ZD carried out imaging and histological assessment and helped to perform the statistical analysis. WD, HL, CL, and YZ performed the IACL-R of mini pigs and gait assessment. All authors read and approved the final manuscript.</p>
</sec>
<sec id="s8">
<title>Funding</title>
<p>The project was funded by the International Science and Technology Cooperation Program of China (Grant No. 2015DFA33050); Doctoral Fund Project of the Second Hospital of Shanxi Medical University (Grant No. 202001-8); Hainan Province Clinical Medical Center.</p>
</sec>
<ack>
<p>We would like to thank Yi Xu and Feipeng Song for providing assistance with the imaging examination, and Yipeng Xue, a veterinarian at the Sciences of ShanXi Agricultural Academy Institute of Animal Husbandry and Veterinary, for teaching us animal management. Moreover, we would like to thank Pengfei Han (Heping Hospital Affiliated to Changzhi Medical College), Xiaodong Gu (Bethune Hospital, Shanxi Medical University) and Pengcui Li (The Second Hospital of Shanxi Medical University) for providing assistance with the minipig model of IACL-R.</p>
</ack>
<sec sec-type="COI-statement" id="s9">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="s10">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec id="s11">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fphar.2022.849102/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fphar.2022.849102/full&#x23;supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="DataSheet1.DOCX" id="SM1" mimetype="application/DOCX" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barenius</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Sari</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Adel</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Robert</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Louise</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Karl</surname>
<given-names>E.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Increased risk of osteoarthritis after anterior cruciate ligament reconstruction: A 14-year follow-up study of a randomized controlled trial</article-title>. <source>Am. J. Sports Med.</source> <volume>42</volume> (<issue>5</issue>), <fpage>1049</fpage>&#x2013;<lpage>1057</lpage>. <pub-id pub-id-type="doi">10.1177/0363546514526139</pub-id> </citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bj&#xf6;rnsson</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Samuelsson</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Sundemo</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Desai</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Sernert</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Rostg&#xe5;rd-Christensen</surname>
<given-names>L.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>A randomized controlled trial with mean 16-year follow-up comparing hamstring and patellar tendon autografts in anterior cruciate ligament reconstruction</article-title>. <source>Am. J. Sports Med.</source> <volume>44</volume> (<issue>9</issue>), <fpage>2304</fpage>&#x2013;<lpage>2313</lpage>. <pub-id pub-id-type="doi">10.1177/0363546516646378</pub-id> </citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bryan</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Heard</surname>
<given-names>Y. A.</given-names>
</name>
<name>
<surname>Chung</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Nigel</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Shrive</surname>
<given-names>C. B.</given-names>
</name>
<etal/>
</person-group> (<year>2011</year>). <article-title>Early joint tissue changes are highly correlated with a set of inflammatory and degradative synovial biomarkers after ACL autograft and its sham surgery in an ovine model</article-title>. <source>J. Orthop. Res.</source> <volume>29</volume> (<issue>8</issue>), <fpage>1185</fpage>&#x2013;<lpage>1192</lpage>. <pub-id pub-id-type="doi">10.1002/jor.21404</pub-id> </citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Capin</surname>
<given-names>J. J.</given-names>
</name>
<name>
<surname>Khandha</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Zarzycki</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Manal</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Buchanan</surname>
<given-names>T. S.</given-names>
</name>
<name>
<surname>Snyder-Mackler</surname>
<given-names>L.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Gait mechanics after ACL reconstruction differ according to medial meniscal treatment</article-title>. <source>J. Bone Jt. Surg. Am.</source> <volume>100</volume> (<issue>14</issue>), <fpage>1209</fpage>&#x2013;<lpage>1216</lpage>. <pub-id pub-id-type="doi">10.2106/JBJS.17.01014</pub-id> </citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chung</surname>
<given-names>T. J.</given-names>
</name>
<name>
<surname>Hsu</surname>
<given-names>K. Y.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>J. H.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>J. S.</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>H. W.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>P. F.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>Association of salivary alpha 2-macroglobulin levels and clinical characteristics in type 2 diabetes</article-title>. <source>J. Diabetes Investig.</source> <volume>7</volume> (<issue>2</issue>), <fpage>190</fpage>&#x2013;<lpage>196</lpage>. <pub-id pub-id-type="doi">10.1111/jdi.12382</pub-id> </citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cuellar</surname>
<given-names>J. M.</given-names>
</name>
<name>
<surname>Cuellar</surname>
<given-names>V. G.</given-names>
</name>
<name>
<surname>Scuderi</surname>
<given-names>G. J.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>&#x3b1;2-Macroglobulin: Autologous protease inhibition technology</article-title>. <source>Phys. Med. Rehabil. Clin. N. Am.</source> <volume>27</volume> (<issue>4</issue>), <fpage>909</fpage>&#x2013;<lpage>918</lpage>. <pub-id pub-id-type="doi">10.1016/j.pmr.2016.06.008</pub-id> </citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gu</surname>
<given-names>X. D.</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>P. C.</given-names>
</name>
<name>
<surname>Che</surname>
<given-names>X. D.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>R. P.</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>P. F.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Adenovirus-mediated transduction with Histone Deacetylase 4 ameliorates disease progression in an osteoarthritis rat model</article-title>. <source>Int. Immunopharmacol.</source> <volume>75</volume>, <fpage>105752</fpage>. <pub-id pub-id-type="doi">10.1016/j.intimp.2019.105752</pub-id> </citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guo</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>P.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Ipriflavone attenuates the degeneration of cartilage by blocking the Indian hedgehog pathway</article-title>. <source>Arthritis Res. Ther.</source> <volume>21</volume> (<issue>1</issue>), <fpage>109</fpage>. <pub-id pub-id-type="doi">10.1186/s13075-019-1895-x</pub-id> </citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Han</surname>
<given-names>P. F.</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Duan</surname>
<given-names>Z. Q.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Z. L.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>T. Y.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>J. G.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Contribution of IL-1&#x3b2;, 6 and TNF-&#x3b1; to the form of post-traumatic osteoarthritis induced by "idealized" anterior cruciate ligament reconstruction in a porcine model</article-title>. <source>Int. Immunopharmacol.</source> <volume>65</volume>, <fpage>212</fpage>&#x2013;<lpage>220</lpage>. <pub-id pub-id-type="doi">10.1016/j.intimp.2018.10.007</pub-id> </citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Heard</surname>
<given-names>B. J.</given-names>
</name>
<name>
<surname>Solbak</surname>
<given-names>N. M.</given-names>
</name>
<name>
<surname>Chung</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Achari</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Shrive</surname>
<given-names>N. G.</given-names>
</name>
<name>
<surname>Frank</surname>
<given-names>C. B.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>The infrapatellar fat pad is affected by injury induced inflammation in the rabbit knee: Use of dexamethasone to mitigate damage</article-title>. <source>Inflamm. Res.</source> <volume>65</volume> (<issue>6</issue>), <fpage>459</fpage>&#x2013;<lpage>470</lpage>. <pub-id pub-id-type="doi">10.1007/s00011-016-0928-z</pub-id> </citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ho</surname>
<given-names>A. S.</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>C. C.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>S. C.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>M. L.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>J. Y.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>W. M.</given-names>
</name>
<etal/>
</person-group> (<year>2010</year>). <article-title>Novel biomarkers predict liver fibrosis in hepatitis C patients: Alpha 2 macroglobulin, vitamin D binding protein and apolipoprotein AI</article-title>. <source>J. Biomed. Sci.</source> <volume>17</volume> (<issue>1</issue>), <fpage>58</fpage>. <pub-id pub-id-type="doi">10.1186/1423-0127-17-58</pub-id> </citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hu</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Dou</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Microenvironment in subchondral bone: Predominant regulator for the treatment of osteoarthritis</article-title>. <source>Ann. Rheum. Dis.</source> <volume>80</volume> (<issue>4</issue>), <fpage>413</fpage>&#x2013;<lpage>422</lpage>. <pub-id pub-id-type="doi">10.1136/annrheumdis-2020-218089</pub-id> </citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hughes-Oliver</surname>
<given-names>C. N.</given-names>
</name>
<name>
<surname>Srinivasan</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Schmitt</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Queen</surname>
<given-names>R. M.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Gender and limb differences in temporal gait parameters and gait variability in ankle osteoarthritis</article-title>. <source>Gait Posture</source> <volume>65</volume>, <fpage>228</fpage>&#x2013;<lpage>233</lpage>. <pub-id pub-id-type="doi">10.1016/j.gaitpost.2018.07.180</pub-id> </citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kellgren</surname>
<given-names>J. H.</given-names>
</name>
<name>
<surname>Lawrence</surname>
<given-names>J. S.</given-names>
</name>
</person-group> (<year>1957</year>). <article-title>Radiological assessment of osteo-arthrosis</article-title>. <source>Ann. Rheum. Dis.</source> <volume>16</volume> (<issue>4</issue>), <fpage>494</fpage>&#x2013;<lpage>502</lpage>. <pub-id pub-id-type="doi">10.1136/ard.16.4.494</pub-id> </citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Kong</surname>
<given-names>X. B.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>X. Y.</given-names>
</name>
<name>
<surname>Zhong</surname>
<given-names>W. Z.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>J. Y.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Protective role of &#x3b1;2-macroglobulin against jaw osteoradionecrosis in a preclinical rat model</article-title>. <source>J. Oral Pathol. Med.</source> <volume>48</volume> (<issue>2</issue>), <fpage>166</fpage>&#x2013;<lpage>173</lpage>. <pub-id pub-id-type="doi">10.1111/jop.12809</pub-id> </citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Lv</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Geng</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>P.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Positive effects of a young systemic environment and high growth differentiation factor 11 levels on chondrocyte proliferation and cartilage matrix synthesis in old mice</article-title>. <source>Arthritis Rheumatol.</source> <volume>72</volume> (<issue>7</issue>), <fpage>1123</fpage>&#x2013;<lpage>1133</lpage>. <pub-id pub-id-type="doi">10.1002/art.41230</pub-id> </citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Xiang</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>P.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Early supplemental &#x3b1;2-macroglobulin attenuates cartilage and bone damage by inhibiting inflammation in collagen II-induced arthritis model</article-title>. <source>Int. J. Rheum. Dis.</source> <volume>22</volume> (<issue>4</issue>), <fpage>654</fpage>&#x2013;<lpage>665</lpage>. <pub-id pub-id-type="doi">10.1111/1756-185X.13457</pub-id> </citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lieberthal</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Sambamurthy</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Scanzello</surname>
<given-names>C. R.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Inflammation in joint injury and post-traumatic osteoarthritis</article-title>. <source>Osteoarthr. Cartil.</source> <volume>23</volume> (<issue>11</issue>), <fpage>1825</fpage>&#x2013;<lpage>1834</lpage>. <pub-id pub-id-type="doi">10.1016/j.joca.2015.08.015</pub-id> </citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Little</surname>
<given-names>C. B.</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>M. M.</given-names>
</name>
<name>
<surname>Cake</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Read</surname>
<given-names>R. A.</given-names>
</name>
<name>
<surname>Murphy</surname>
<given-names>M. J.</given-names>
</name>
<name>
<surname>Barry</surname>
<given-names>F. P.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>The OARSI histopathology initiative - recommendations for histological assessments of osteoarthritis in sheep and goats</article-title>. <source>Osteoarthr. Cartil.</source> <volume>18</volume>, <fpage>S80</fpage>&#x2013;<lpage>S92</lpage>. <pub-id pub-id-type="doi">10.1016/j.joca.2010.04.016</pub-id> </citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maerz</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Sherman</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Newton</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Yilmaz</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kumar</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Graham</surname>
<given-names>S. F.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Metabolomic serum profiling after ACL injury in rats: A pilot study implicating inflammation and immune dysregulation in post-traumatic osteoarthritis</article-title>. <source>J. Orthop. Res.</source> <volume>36</volume> (<issue>7</issue>), <fpage>1969</fpage>&#x2013;<lpage>1979</lpage>. <pub-id pub-id-type="doi">10.1002/jor.23854</pub-id> </citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Misir</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Yildiz</surname>
<given-names>K. I.</given-names>
</name>
<name>
<surname>Kizkapan</surname>
<given-names>T. B.</given-names>
</name>
<name>
<surname>Incesoy</surname>
<given-names>M. A.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Kellgren-Lawrence grade of osteoarthritis is associated with change in certain morphological parameters</article-title>. <source>Knee</source> <volume>27</volume> (<issue>3</issue>), <fpage>633</fpage>&#x2013;<lpage>641</lpage>. <pub-id pub-id-type="doi">10.1016/j.knee.2020.04.013</pub-id> </citation>
</ref>
<ref id="B22">
<citation citation-type="confproc">
<person-group person-group-type="author">
<name>
<surname>Montesano</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Cuellar</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2015</year>). &#x201c;<article-title>Improving response to treatment for patients with DDD by the use of molecular markers</article-title>,&#x201d; in <conf-name>2015. 4th International Conference on Orthopedics &#x26; Rheumatology</conf-name>, <conf-loc>Baltimore, Maryland, USA</conf-loc>, <conf-date>October 26-28, 2015</conf-date>. </citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Muramatsu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Sasho</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Saito</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Yamaguchi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Akagi</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Mukoyama</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>Preventive effects of hyaluronan from deterioration of gait parameters in surgically induced mice osteoarthritic knee model</article-title>. <source>Osteoarthr. Cartil.</source> <volume>22</volume> (<issue>6</issue>), <fpage>831</fpage>&#x2013;<lpage>835</lpage>. <pub-id pub-id-type="doi">10.1016/j.joca.2014.03.016</pub-id> </citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pan</surname>
<given-names>L. P.</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>Y. P.</given-names>
</name>
<name>
<surname>Wen</surname>
<given-names>L. C.</given-names>
</name>
<name>
<surname>Chai</surname>
<given-names>W. B.</given-names>
</name>
<name>
<surname>Jun-Bao</surname>
<given-names>D. U.</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>H. F.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>Hydrogen sulfide in cartilage and its inhibitory effect on matrix metalloproteinase 13 expression in chondrocytes induced by interlukin-1&#x3b2;</article-title>. <source>Beijing Da Xue Xue Bao Yi Xue Ban.</source> <volume>48</volume> (<issue>2</issue>), <fpage>194</fpage>&#x2013;<lpage>202</lpage>. PMID: 27080266 </citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pauli</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Grogan</surname>
<given-names>S. P.</given-names>
</name>
<name>
<surname>Patil</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Otsuki</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Hasegawa</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Koziol</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2011</year>). <article-title>Macroscopic and histopathologic analysis of human knee menisci in aging and osteoarthritis</article-title>. <source>Osteoarthr. Cartil.</source> <volume>19</volume> (<issue>9</issue>), <fpage>1132</fpage>&#x2013;<lpage>1141</lpage>. <pub-id pub-id-type="doi">10.1016/j.joca.2011.05.008</pub-id> </citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pozzi</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Snyder-Mackler</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Zeni</surname>
<given-names>J.</given-names>
<suffix>Jr.</suffix>
</name>
</person-group> (<year>2015</year>). <article-title>Relationship between biomechanical asymmetries during a step up and over task and stair climbing after total knee arthroplasty</article-title>. <source>Clin. Biomech.</source> <volume>30</volume> (<issue>1</issue>), <fpage>78</fpage>&#x2013;<lpage>85</lpage>. <pub-id pub-id-type="doi">10.1016/j.clinbiomech.2014.11.001</pub-id> </citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rashid</surname>
<given-names>M. H.</given-names>
</name>
<name>
<surname>Theberge</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Elmes</surname>
<given-names>S. J.</given-names>
</name>
<name>
<surname>Perkins</surname>
<given-names>M. N.</given-names>
</name>
<name>
<surname>Mcintosh</surname>
<given-names>F.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Pharmacological validation of early and late phase of rat mono-iodoacetate model using the Tekscan system</article-title>. <source>Eur. J. Pain</source> <volume>17</volume> (<issue>2</issue>), <fpage>210</fpage>&#x2013;<lpage>222</lpage>. <pub-id pub-id-type="doi">10.1002/j.1532-2149.2012.00176.x</pub-id> </citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rehman</surname>
<given-names>A. A.</given-names>
</name>
<name>
<surname>Ahsan</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Khan</surname>
<given-names>F. H.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>&#x3b1;-2-Macroglobulin: A physiological guardian</article-title>. <source>J. Cell. Physiol.</source> <volume>228</volume> (<issue>8</issue>), <fpage>1665</fpage>&#x2013;<lpage>1675</lpage>. <pub-id pub-id-type="doi">10.1002/jcp.24266</pub-id> </citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ruan</surname>
<given-names>M. Z. C.</given-names>
</name>
<name>
<surname>Patel</surname>
<given-names>R. M.</given-names>
</name>
<name>
<surname>Dawson</surname>
<given-names>B. C.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>M. M.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>B. H. L.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Pain, motor and gait assessment of murine osteoarthritis in a cruciate ligament transection model</article-title>. <source>Osteoarthr. Cartil.</source> <volume>21</volume> (<issue>9</issue>), <fpage>1355</fpage>&#x2013;<lpage>1364</lpage>. <pub-id pub-id-type="doi">10.1016/j.joca.2013.06.016</pub-id> </citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Salvesen</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Enghild</surname>
<given-names>J. J.</given-names>
</name>
</person-group> (<year>1993</year>). <article-title>alpha-Macroglobulins: detection and characterization</article-title>. <source>Methods Enzymol.</source> <volume>223</volume>, <fpage>121</fpage>&#x2013;<lpage>141</lpage>. <pub-id pub-id-type="doi">10.1016/0076-6879(93)23041-k</pub-id> </citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shah</surname>
<given-names>K. C.</given-names>
</name>
<name>
<surname>Linsley</surname>
<given-names>C. S.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>B. M.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Evaluation of a shape memory implant abutment system: An up to 6-month pilot clinical study</article-title>. <source>J. Prosthet. Dent.</source> <volume>123</volume> (<issue>2</issue>), <fpage>257</fpage>&#x2013;<lpage>263</lpage>. <pub-id pub-id-type="doi">10.1016/j.prosdent.2018.11.012</pub-id> </citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sottrup-Jensen</surname>
<given-names>L.</given-names>
</name>
</person-group> (<year>1989</year>). <article-title>Alpha-macroglobulins: Structure, shape, and mechanism of proteinase complex formation</article-title>. <source>J. Biol. Chem.</source> <volume>264</volume> (<issue>20</issue>), <fpage>11539</fpage>&#x2013;<lpage>11542</lpage>. </citation>
</ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>L. J.</given-names>
</name>
<name>
<surname>Zeng</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>Z. P.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>J. T.</given-names>
</name>
<name>
<surname>Ni</surname>
<given-names>G. X.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Post-traumatic osteoarthritis following ACL injury</article-title>. <source>Arthritis Res. Ther.</source> <volume>24</volume> (<issue>1</issue>), <fpage>57</fpage>. <pub-id pub-id-type="doi">10.1186/s13075-020-02156-5</pub-id> </citation>
</ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Q.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>Identification of &#x3b1;2-macroglobulin as a master inhibitor of cartilage-degrading factors that attenuates the progression of posttraumatic osteoarthritis</article-title>. <source>Arthritis Rheumatol.</source> <volume>66</volume> (<issue>7</issue>), <fpage>1843</fpage>&#x2013;<lpage>1853</lpage>. <pub-id pub-id-type="doi">10.1002/art.38576</pub-id> </citation>
</ref>
<ref id="B35">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wei</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Fleming</surname>
<given-names>B. C.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Teeple</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Jay</surname>
<given-names>G. D.</given-names>
</name>
<etal/>
</person-group> (<year>2010</year>). <article-title>Comparison of differential biomarkers of osteoarthritis with and without posttraumatic injury in the Hartley Guinea pig model</article-title>. <source>J. Orthop. Res.</source> <volume>28</volume> (<issue>7</issue>), <fpage>900</fpage>&#x2013;<lpage>906</lpage>. <pub-id pub-id-type="doi">10.1002/jor.21093</pub-id> </citation>
</ref>
<ref id="B36">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xue</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Self-reported weather sensitivity is associated with clinical symptoms and structural abnormalities in patients with knee osteoarthritis: A cross-sectional study</article-title>. <source>Rheumatol. Ther.</source> <volume>8</volume> (<issue>3</issue>), <fpage>1405</fpage>&#x2013;<lpage>1417</lpage>. <pub-id pub-id-type="doi">10.1007/s40744-021-00340-w</pub-id> </citation>
</ref>
<ref id="B37">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Browning</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Scuderi</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Hanna</surname>
<given-names>L. S.</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>L.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Targeted designed variants of alpha-2-macroglobulin (A2M) attenuate cartilage degeneration in a rat model of osteoarthritis induced by anterior cruciate ligament transection</article-title>. <source>Arthritis Res. Ther.</source> <volume>19</volume> (<issue>1</issue>), <fpage>175</fpage>. <pub-id pub-id-type="doi">10.1186/s13075-017-1363-4</pub-id> </citation>
</ref>
<ref id="B38">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Gu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>H.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Inflammatory factors are crucial for the pathogenesis of post-traumatic osteoarthritis confirmed by a novel porcine model: "Idealized" anterior cruciate ligament reconstruction" and gait analysis</article-title>. <source>Int. Immunopharmacol.</source> <volume>99</volume>, <fpage>107905</fpage>. <pub-id pub-id-type="doi">10.1016/j.intimp.2021.107905</pub-id> </citation>
</ref>
</ref-list>
</back>
</article>